LinkedInXFacebook
Subscribe
Orthopedics This Week
  • Opinions
  • |My Feed
  • |Events
  • |Company Directory
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Spine/Aurora Spine ZIPS Into Britain
Spine

Aurora Spine ZIPS Into Britain

March 10, 2014 1 min read Premium comments

Advertisement

Aurora Spine ZIPS Into Britain
Courtesy: Aurora Spine Corporation
Secondary

The first surgical implant in the United Kingdom of Aurora Spine Corporation’s Zip Ultra, a minimally invasive interspinous device, took place in late February. Stuart James, M.D, performed the surgery at the University Hospital Llandough, a part of the Cardiff and Vale University Health Board.

“The ZIP MIS implant is very well designed. It is both stable and secure. Implanting the device was simple, easy and safe, ” said James who has completed a recognized spine fellowship in Bristol, UK, where he has gained extensive experience in all aspects of spinal disease and spinal conditions. The company’s news release reports that James ‘experience ranges from trauma and tumor work to adult and pediatric complex deformity of the spine. “I will be expanding my use of the product as I believe it has multiple spine fusion indications, ” he said.

James Trent Northcutt, Aurora Spine’s president and CEO said, “We are absolutely thrilled that Aurora now offers our MIS portfolio in the United Kingdom, including the ZIP MIS Interspinous System. We believe that the ZIP device will change spine surgery in the U.S. with a true minimally invasive approach designed to achieve reproducible, superior patient outcomes.”

Aurora Spine is an early stage company focused on bringing new solutions to the spinal implant market.

Author

BW
Biloine W. Young
React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

Orthopedics This Week’s mission is to connect the orthopedic community with the people, ideas, and innovations shaping the future of musculoskeletal care.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Opinions
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, opinions, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy